Professional Documents
Culture Documents
A Refresher On Disinfectant Wet Contact Time
A Refresher On Disinfectant Wet Contact Time
This article emphasizes the importance of wet contact time for effective disinfection.
Wet contact time is one of the critical parameters in choosing a disinfectant (a chemical agent used
for microbial reduction purposes, e.g., sporicide, sanitizer) for use in a classified area. Disinfectant
contact time is commonly known as “wet contact time”, “contact time,” “dwell time,” or “action time.”
The appropriate wet contact time is determined during the disinfectant qualification (coupon studies),
by demonstrating an effective log 10 (log) reduction of microorganisms against a specified wet contact
time. Therefore, the minimum contact time is the time needed for the disinfectant to achieve the
necessary log reduction (1, 2). Consequently, the facility surfaces need to remain wet with the
disinfectant for the contact time that was qualified during the in vitro coupon studies (2, 3).
The regulatory guidance and industry technical documents (4-9) require (bio)pharmaceutical
manufacturers to qualify a disinfectant wet contact time (in vitro testing). Manufacturers are also
required to validate the disinfection process by utilizing the qualified disinfectant wet contact time in
the real world (in situ testing) to demonstrate the effectiveness of the cleaning and disinfection
program. See Figure 1 above.
The qualification of the disinfectant is based on the wet contact time, log reduction acceptance
criteria, disinfectant concentration, water quality, surface types, and the microbial kill. The wet
contact time during in vitro testing generally depends on the:
Microbial kill
Disinfectant formulation
Disinfectant concentration
Clearoom Surface
The wet contact time and the inactivation of microorganisms in the cleanroom (real-world setting)
generally depends on the:
Conclusion
It is clear from a scientific, regulatory expectation, and critical process control perspective, that
achieving a minimum wet contact time is essential for maintaining an effective disinfection process
and preventing microbial contamination proactively. The validated wet contact time allows for
demonstrated, effective inactivation of microorganisms in the cleanroom, irrespective of cleanroom
parameters or application techniques, that may affect the duration of time the surface stays wet on
the cleanroom surface. Disinfectant activity is halted or significantly reduced when insufficient liquid
is present, and it is not possible to adequately control the disinfection process, without a minimum
wet contact time. Consequently, if a minimum wet contact time is not achieved, the disinfection
process effectiveness is not assured, and the manufacturer’s risk is increased.
Partager l’article
Partager
Walid El Azab – Steris
Walid El Azab is an Industrial pharmacist, a Qualified Person (QP), a green belt certified and is a
Technical Services Manager for STERIS. His areas of expertise include both upstream and
downstream pharmaceutical operation and validation in non-sterile and sterile process. Walid’s
responsibilities and experience have also included project management, handling deviations and
complaints, releasing raw materials, drug products and investigational medicinal product (IMP),
conducting external audits of suppliers, and leading customer and regulatory audits and develop
strategy approach for process, cleaning, and system gap analysis.
walid_elazab@steris.com
References
✻
[1] Sandle T., Pharmaceutical Microbiology: Essentials for Quality Assurance and Quality Control, Woodhead
publishing p.191
[2] Sandle T., Cleaning and disinfection. Accessed on the 28 June 2018:
http://182.160.97.198:8080/xmlui/bitstream/handle/123456789/1014/Chapter%2015-Cleaning-and-disinfection.pdf?
sequence=17
[3] Sandle T., Selecting of Cleanroom Disinfectants, Lavague 42, edition June 2014
[4] EudraLex – Volume 4 – Good Manufacturing Practice (GMP) guidelines, Annex 1, Manufacture of Sterile
Medicinal Products, 2008
[5] EudraLex – Volume 4 – Good Manufacturing Practice (GMP) guidelines, Annex 1 Manufacture of Sterile
Medicinal Products, Draft 2020 V12
[6] PI 007_6: “validation of aseptic processes”
[7] FDA, Sterile Drug Products Produced by Aseptic Processing — Current Good Manufacturing Practice, 2004
[8] United States Pharmacopeia (USP) 42 <1072> Disinfectants and Antiseptics, 2019
[9] Parenteral Drug Association Technical Report 70 Fundamentals of Cleaning and Disinfection Programs for
Aseptic Manufacturing Facilities, 2015
[10] West AM, Teska PJ, Haley FO (2019), There is not additional bactericidal efficacy of environmental protection
agency registered disinfectant towellettes after surface drying, American Journal Infection Control, 47:27-32
[11] U.S. Food and Drug Administration, Form 483 https://www.fda.gov/media/114920/download
Accessed 25FEB2020
[12] U.S. Food and Drug Administration, Form 483 https://www.fda.gov/media/131131/download
Accessed 25FEB2020